Ausgabe 2/2012
Inhalt (8 Artikel)
Original Paper
Towards a social discount rate for the economic evaluation of health technologies in Germany: an exploratory analysis
Mareike Schad, Jürgen John
Original Paper
Cost-effectiveness of treatment with etanercept for psoriasis in Sweden
Christopher Knight, Josephine Mauskopf, Mats Ekelund, Amitabh Singh, Shiyi Yang, Robert Boggs
Original Paper
Malpractice liability, technology choice and negative defensive medicine
Eberhard Feess
Original Paper
Decision-making in general practice: the effect of financial incentives on the use of laboratory analyses
Siri Fauli Munkerud
Original Paper
Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam
Steven J. Edwards, Sarah Wordsworth, Mike J. Clarke
Original Paper
Exploring the disparities of regional health care expenditures in Switzerland: some empirical evidence
Oliver Reich, Cornelia Weins, Claudia Schusterschitz, Magdalena Thöni
Open Access
Original Paper
Defining care products to finance health care in the Netherlands
Machiel Westerdijk, Joost Zuurbier, Martijn Ludwig, Sarah Prins